Proven History and Technology
The First Choice in the Interventional Treatment of PE
The New Standard of Care for Pulmonary Embolism Treatment
EKOS was the first interventional device for treating PE. Today, it’s trusted by more clinicians than any other PE device.
- 2005 First Patient Case
- 2008 EKOS Receives Peripheral Vascular Indication
- 2008 First DVT Data Published
- 2014 EKOS Receives PE Indication
- 2014 ULTIMA – Level 1 PE Data Published
- 2015 SEATTLE II - Pivotal PE Trial Published
- 2018 OPTALYSE PE – Optimized PE Protocol; Long-Term Patient Outcomes
- 2018 ACCESS PTS – First Chronic DVT Data Published
One 15-minute Procedure Can Deliver Dramatic Results
How EKOS Works
EKOS ultrasound technology unwinds and thins fibrin strands to expose more drug receptor sites; acoustic streaming drives the drug deeper into the clot.
Clinically Proven to be Safe and Reliable with Long-Term Outcomes
- Minimally invasive, 15-minute procedure that is easy to perform
- Requires less lytic agent: as low as 8 mg tPA used1
- Prescribed protocol that allows for predictable procedural workflow and proven patient outcomes
Stay up to date
Receive emails on the latest advances, EKOS clinical data and news.
Start using EKOS
Contact an EKOS Consultant today.
1. Tapson V et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism. JACC: Cardiovascular Interventions 2018; 11(14):1401-1410.